Patent · US Active

Biophotonic compositions for the treatment of otitis externa

US10610513B2 · kind B2 · utility

2Cited by

15References

20Claims

0Family size

Assignee

KLOX TECHNOLOGIES INC. · IE

Inventors

Francesco Bellini · Calgary, CA
Matteo Cerquetella · Fabriano, IT
Adolfo Maria Tambella · Fabriano, IT
Andrea SPATERNA · Fabriano, IT
Nikolaos Loupis · Athens, GR
David Ohayon · Montréal, CA
Remigio Piergallini · Ascoli Piceno, IT

Key dates

Filing date	Jan 11, 2017
Grant date	Apr 7, 2020
Priority date	—
Expiry date	Jan 11, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2300/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure describes methods and uses of biophotonic compositions which comprise at least one oxidant and at least one chromophore capable of activating the oxidant, in association with a pharmacologically acceptable carrier for the treatment of otitis externa.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.